430 related articles for article (PubMed ID: 27932455)
61. Tissue-specific RNA expression marks distant-acting developmental enhancers.
Wu H; Nord AS; Akiyama JA; Shoukry M; Afzal V; Rubin EM; Pennacchio LA; Visel A
PLoS Genet; 2014 Sep; 10(9):e1004610. PubMed ID: 25188404
[TBL] [Abstract][Full Text] [Related]
62. Multi-omics analysis reveals the functional transcription and potential translation of enhancers.
Wu Y; Yang Y; Gu H; Tao B; Zhang E; Wei J; Wang Z; Liu A; Sun R; Chen M; Fan Y; Mao R
Int J Cancer; 2020 Oct; 147(8):2210-2224. PubMed ID: 32573785
[TBL] [Abstract][Full Text] [Related]
63. The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages.
Huang Z; Liang N; Goñi S; Damdimopoulos A; Wang C; Ballaire R; Jager J; Niskanen H; Han H; Jakobsson T; Bracken AP; Aouadi M; Venteclef N; Kaikkonen MU; Fan R; Treuter E
Mol Cell; 2021 Mar; 81(5):953-968.e9. PubMed ID: 33503407
[TBL] [Abstract][Full Text] [Related]
64. Transcription decouples estrogen-dependent changes in enhancer-promoter contact frequencies and spatial proximity.
Gómez Acuña LI; Flyamer I; Boyle S; Friman ET; Bickmore WA
PLoS Genet; 2024 May; 20(5):e1011277. PubMed ID: 38781242
[TBL] [Abstract][Full Text] [Related]
65. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
Cai YM; Lu ZQ; Li B; Huang JY; Zhang M; Chen C; Fan LY; Ma QY; He CY; Chen SN; Jiang Y; Li YM; Ning CB; Zhang FW; Wang WZ; Liu YZ; Zhang H; Jin M; Wang XY; Han JX; Xiong Z; Cai M; Huang CQ; Yang XJ; Zhu X; Zhu Y; Miao XP; Zhang SK; Wei YC; Tian JB
Mil Med Res; 2024 Jun; 11(1):36. PubMed ID: 38863031
[TBL] [Abstract][Full Text] [Related]
66. Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.
Nagari A; Murakami S; Malladi VS; Kraus WL
Methods Mol Biol; 2017; 1468():121-38. PubMed ID: 27662874
[TBL] [Abstract][Full Text] [Related]
67. Enhancer RNAs and regulated transcriptional programs.
Lam MT; Li W; Rosenfeld MG; Glass CK
Trends Biochem Sci; 2014 Apr; 39(4):170-82. PubMed ID: 24674738
[TBL] [Abstract][Full Text] [Related]
68. Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation.
Chen H; Du G; Song X; Li L
Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):201-207. PubMed ID: 28599852
[TBL] [Abstract][Full Text] [Related]
69. The emerging roles of eRNAs in transcriptional regulatory networks.
Mousavi K; Zare H; Koulnis M; Sartorelli V
RNA Biol; 2014; 11(2):106-10. PubMed ID: 24525859
[TBL] [Abstract][Full Text] [Related]
70. Predicting active enhancers with DNA methylation and histone modification.
Luo X; Li Q; Tang Y; Liu Y; Zou Q; Zheng J; Zhang Y; Xu L
BMC Bioinformatics; 2023 Nov; 24(1):414. PubMed ID: 37919681
[TBL] [Abstract][Full Text] [Related]
71. Modulation of Brain Pathology by Enhancer RNAs in Cerebral Ischemia.
Bhattarai S; Akella A; Gandhi A; Dharap A
Mol Neurobiol; 2021 Apr; 58(4):1482-1490. PubMed ID: 33201427
[TBL] [Abstract][Full Text] [Related]
72. An Emerging Role for Enhancer RNAs in Brain Disorders.
Patel A; Dharap A
Neuromolecular Med; 2024 Mar; 26(1):7. PubMed ID: 38546891
[TBL] [Abstract][Full Text] [Related]
73. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions.
Gothard LQ; Hibbard JC; Seyfred MA
Mol Endocrinol; 1996 Feb; 10(2):185-95. PubMed ID: 8825558
[TBL] [Abstract][Full Text] [Related]
74. Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects.
Wan L; Li W; Meng Y; Hou Y; Chen M; Xu B
Front Immunol; 2022; 13():849451. PubMed ID: 35514959
[TBL] [Abstract][Full Text] [Related]
75. Intragenic Enhancers Attenuate Host Gene Expression.
Cinghu S; Yang P; Kosak JP; Conway AE; Kumar D; Oldfield AJ; Adelman K; Jothi R
Mol Cell; 2017 Oct; 68(1):104-117.e6. PubMed ID: 28985501
[TBL] [Abstract][Full Text] [Related]
76. Mixed lineage leukemia histone methylases play critical roles in estrogen-mediated regulation of HOXC13.
Ansari KI; Kasiri S; Hussain I; Mandal SS
FEBS J; 2009 Dec; 276(24):7400-11. PubMed ID: 19922474
[TBL] [Abstract][Full Text] [Related]
77. Production of Spliced Long Noncoding RNAs Specifies Regions with Increased Enhancer Activity.
Gil N; Ulitsky I
Cell Syst; 2018 Nov; 7(5):537-547.e3. PubMed ID: 30447999
[TBL] [Abstract][Full Text] [Related]
78. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
[TBL] [Abstract][Full Text] [Related]
79. Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the β-globin locus.
Kim YW; Lee S; Yun J; Kim A
Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25588787
[TBL] [Abstract][Full Text] [Related]
80. Identification of Transcribed Enhancers by Genome-Wide Chromatin Immunoprecipitation Sequencing.
Blinka S; Reimer MH; Pulakanti K; Pinello L; Yuan GC; Rao S
Methods Mol Biol; 2017; 1468():91-109. PubMed ID: 27662872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
